# Safety and Tolerability Study of N6022 in Healthy Subjects

> **NCT01147406** · PHASE1 · COMPLETED · sponsor: **Nivalis Therapeutics, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** N6022
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01147406
- **Lead sponsor:** Nivalis Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147406, "Safety and Tolerability Study of N6022 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01147406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*